Form 4 for ABBV AbbVie
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001415889-24-006161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | 2024-02-28 | ABBV | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | F - Tax | $178.99 | -26.1K | 93.8K | -22% | -$4.68M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2024-02-28 | F | D | 26,121 | $178.99 | 93,780 | D | — | — |